Global Lyme Disease Testing Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch's in-depth investigation and research, the global Lyme Disease Testing market size will reach 259.16 Million USD in 2025 and is projected to reach 408.32 Million USD by 2032, with a CAGR of 6.71% (2025-2032). Notably, the China Lyme Disease Testing market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Lyme disease testing refers to the diagnostic procedures used to detect the presence of Lyme disease, a tick-borne illness caused by the bacterium Borrelia burgdorferi. The primary method of Lyme disease testing involves serological tests that detect antibodies produced by the immune system in response to the infection. The most common serological tests include the enzyme immunoassay (EIA) and the Western blot test. The EIA is typically used as a screening test and if positive or equivocal, the Western blot test is performed to confirm the diagnosis. These tests detect specific antibodies against the Lyme disease bacteria. However, it is essential to note that the accuracy of these tests can vary, and false-negative results are possible, especially during the early stages of infection when antibody levels may be low. In some cases, additional laboratory tests, such as polymerase chain reaction (PCR) testing or culture of the bacteria, may be used to directly detect the presence of the bacterium in blood, joint fluid, or tissues. The interpretation of test results should be done in conjunction with clinical symptoms and exposure history to ensure accurate diagnosis and appropriate treatment of Lyme disease. Consulting with a healthcare professional is crucial for proper testing and interpretation.

The major global suppliers of Lyme Disease Testing include Quidel Corporation, Roche Holding AG, Fujirebio(H.U. Group Holdings), ZEUS Scientific, IGeneX, Thermo Fisher Scientific, Everlywell, Oxford Immunotec Global PLC(PerkinElmer), Bio-Rad Laboratories, BioMerieux, T1 Biosystems, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Lyme Disease Testing. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Lyme Disease Testing market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Lyme Disease Testing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Lyme Disease Testing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Lyme Disease Testing Include:

Quidel Corporation

Roche Holding AG

Fujirebio(H.U. Group Holdings)

ZEUS Scientific

IGeneX

Thermo Fisher Scientific

Everlywell

Oxford Immunotec Global PLC(PerkinElmer)

Bio-Rad Laboratories

BioMerieux

T1 Biosystems

Lyme Disease Testing Product Segment Include:

ELISA

Western Blotting

PCR

Others

Lyme Disease Testing Product Application Include:

Hospital and Testing Agency

Personal

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Lyme Disease Testing Industry PESTEL Analysis

Chapter 3: Global Lyme Disease Testing Industry Porter's Five Forces Analysis

Chapter 4: Global Lyme Disease Testing Major Regional Market Size (Revenue) and Forecast Analysis

Chapter 5: Global Lyme Disease Testing Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 6: Global Lyme Disease Testing Revenue and Forecast Analysis by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 8: Industrial Chain Analysis, Lyme Disease Testing Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources